drugset / Trial / NCT06921941

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Digoxin and Rosuvastatin

NCT06921941

Phase 1 Completed 38 enrolled Atea Pharmaceuticals, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

Drug-drug interaction study between Bemnifosbuvir/Ruzasvir and Digoxin or Rosuvastatin

Timeline

Start
2025-04-08
Primary completion
2025-07-02
Completion
2025-07-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Bemnifosbuvir Other / unclassified Oral
Subject Digoxin Other / unclassified
Subject Rosuvastatin Small molecule
Subject Ruzasvir Other / unclassified Oral

Indications

No indication recorded.